Regional cerebral blood flow (CBF) was studied in 51 young schizophrenics. A significant de crease of CBF was seen in frontal and prefrontal regions (hypofrontal pattern) in chronic patients whose disease had evolved for more than 2 years and who were in re mission. This hypofrontal pattern was reversible, as it disappeared during exacerbation of the disease. In 10 pa tients who had not been treated with neuroleptics for sev-
Since the first publication of Ingvar and Franzen (1974) , several laboratories have reported that pa tients with schizophrenia show decreased blood flow (Ariel et aI., 1983; Devous et aI., 1985; Geraud et aI., 1985; Kurachi et aI., 1985; Warkentin et aI., 1985) or glucose utilization (Farkas et aI., 1980; Buchsbaum et aI., 1982; Brodie et aI., 1983; Widen et aI., 1983; Volkow et aI., 1985) in the frontal lobes.
The present study, involving a population of young schizophrenics under 40 years of age, was aimed at better defining the clinical profile of hypo frontal schizophrenics, as wel l as determining whether hemodynamic hypofrontality constitutes an irreversible situation or merely reflects a revers ible functional phenomenon.
METHODS
Fifty-one schizophrenic patients were studied (35 men and 16 women, mean age 26.4 ± 8 years) and compared with 36 normal control subjects (22 men and 14 women, mean age 25.9 ± 9.4 years). Diagnosis of schizophrenia was made by a psychiatric team, according to the DSM III criteria. The distribution of patients in terms of clin-eral weeks, we found a dopaminergic hypersensitivity in the frontal lobes, as a weak dose of piribedil restored near-normal frontality. This may reflect either the role of neuroleptic washout or a primitive dopaminergic deple tion, as proposed by some authors in the chronic form of schizophrenia. Key Words: Schizophrenia-Cerebral blood flow -N euroleptics-Dopaminergic agonist Frontal lobe.
ical type, evolutive form, and treatment administered at time of study is presented in Ta ble 1. Washout period lasted 15 days for simple neuroleptics and 45 days for depot form. Mean age of each subgroup is also indicated in Ta ble 1.
Cerebral blood flow (CBF) was measured via the 133Xe inhalation technique, using a 32-detector system (16/ hemisphere). Subjects were recumbent in a silent room, with eyes closed. End-tidal levels of CO2, blood pressure, and pulse rate were recorded at the beginning and at the end of the procedure. The 133Xe inhalation lasted for 1 min. Calculation of blood values was obtained by the ini tial slope index method (lSI), from the clearance of cere bral radioactivity between the second and the third minutes (Risberg et aI., 1975) .
For each subject, mean values were calculated for all 32 detectors (mean hemispheric flow), for the 10 most anterior ones (mean frontal flow), and for the 22 others (mean parieto-temporo-occipital flow). A frontal pattern was calculated as the percentage of variations between the frontal detectors and the others:
In 10 schizophrenics, a second CBF measurement was made after a 30-min intravenous perfusion of a dopami nergic agonist (piribedil, 0.1 mg/kg) by means of an elec trical syringe. Eight of these patients presented the disor ganized and chronic form of schizophrenia and had neu roleptics withdrawn a few weeks earlier. Two patients were subchronics and had never been treated by neuro leptics. Piribedil perfusion and the two CBF measure- Neuroleptics 29
28. 9 ± 8. 6 3. 5 ± 3. 9
Washout 9 27 ± 4 -3 ± 3.8c ments were performed under the same conditions in 10 age-and sex-matched controls. The reproducibility of the method for normal controls studied repeatedly in the same condition was reported earlier (Bes et aI., 1983) .
RESULTS
Mean hemispheric values did not differ among patients (48.9 ± 9) and controls (47.1 ± 8.9). Frontal flow values were lower in schizophrenics (47.9 ± 9.2) than in controls (51.1 ± 9.6), but this difference was not significant. The frontal pattern was significantly decreased in schizophrenics (2.5 ± 4%) in comparison with controls (6.2 ± 3.5%) (t test, p < 0.01). Frontal pattern was not correlated with patient age (r = 0.25).
Correlations of the frontal pattern with clinical parameters are shown in Ta ble 1. The symptomatic form of schizophrenia did not influence frontal patterns, except in the residual form, where all the values were negative (hypofrontal pattern). Chronic schizophrenics had a lower mean frontal pattern than subchronics, but in chronic patients in exacerbation, mean frontal pattern did not differ from frontal pattern in subchronics. The difference between these two subgroups of chronic patients, J Cereb Blood Flow Metab, Vol. 7, No.1, 1987 in remission and in exacerbation, is highly signifi cant, whereas mean age is identical.
There was no difference of frontal pattern be tween treated and nontreated patients. In the washout group, a significant hypofrontal pattern was observed. Piribedil perfusion did not lead to any modification in region CBFs in control sub jects; schizophrenics showed increased CBF levels in the frontal regions, with a significant increase of frontal pattern from -2.3 ± 4% to + 3.2 ± 7.6% (Fig. 1) (paired t test, p < 0.05).
DISCUSSION

Clinical profile of hypofrontal schizophrenics
Few authors have sought to establish a correla tion between the hemodynamic or metabolic ac tivity of the frontal lobes and the clinical form of schizophrenia, most often because of insufficient or overly disparate populations. Kurachi et al. (1985) found a correlation between negative symptoms and hypofrontality, and positive symptoms (audi tory hallucinations) and left side temporal flows. Devous et al. (1985) , using 133Xe tomography, ob tained the opposite results, as hypofrontality was present in 40% of the paranoid patients and only in 11 % of nonparanoid patients. In our study, disorga nized, paranoid, and undifferentiated patients had the same mean frontal pattern. Only those subjects classified according to the DSM-III criteria as re siduals (those showing no manifest psychotic symptoms at the time of examination) fell into a class alone, as all exhibited a hypofrontal pattern.
Thus, it appears difficult to conclude that a correla tion exists between the hemodynamic activity of the frontal lobes and the clinical type of schizo phrenia. Moreover, it is somewhat artificial to radi cally oppose the productive and deficient forms of the disease: one-third of the patients present symptoms of both forms to a different extent (An dreasen and Olsen, 1982) , and it is often very diffi cult to affirm absence of delirious or hallucinatory activity in subject with a "defect" state. The evolutive form of schizophrenia, however, correlates much more closely with hypofrontality (Widen et aI., 1983) . Hypofrontality was initially described by Ingvar and Franzen (1974) in aged, deteriorated schizophrenics-type II as classified by Crow (1980) . Since then, it has been observed in a large number of young schizophrenics under 40 years of age. Nevertheless, it rarely occurs in subchronic schizophrenics in whom the disorder has lasted for less than 2 years (5 of 16 in our popu lation). On the other hand, hypofrontality is seen in nearly all chronic schizophrenics in remission. In deed, in our study, the frontal pattern of most chronic patients with exacerbation fell within the normal range. The majority of teams not reporting hypofrontality studied mainly subacute schizo phrenics who were often in the active phase of the disorder (Sheppard et aI., 1983; Widen et aI., 1983; Warkentin et aI., 1985; Wiesel et aI., 1985) .
DOPAMINERGIC STIMULATION of CB F
We are thus led to conclude that hypofrontality can be seen in young, nondeteriorated schizo phrenics and that it appears only after several years of the disease, essentially during phases of remis sion. This phenomenon can be reversible, being apt to disappear during exacerbation.
Influence of neuroleptics
We did not find a different mean frontal pattern between treated and nontreated subjects. Among nontreated patients, only two had a chronic form making it impossible for us to study the effect of treatment considering the duration of the illness. Nevertheless, we observed a significant difference in the small washout group. The persistence of hy pofrontality in chronic schizophrenics who have been withdrawn from neuroleptics has served as reason for some to reject the influence of neuro leptic treatment. In most cases, however, the with drawal lasted for a short period, a few weeks at most.
Thus, a persistent effect of treatment cannot be excluded, particularly as it is known that biological modifications due to neuroleptics may persist sev eral months after stopping treatment (Clow et aI., 1980) . It should be noted, however, that the patient studied by Farkas et al. (1980) , a 43-year-old chronic schizophrenic who had never received neu-roleptic treatment, exhibited a 40% decrease in glu cose consumption in the frontal lobes.
Dopaminergic stimulation in schizophrenics not treated by neuroleptics McCulloch and Edvinsson (1980) showed that in the monkey, two dopaminergic agonists, piribedil and apomorphine, provoked a parallel increase of cerebral blood flow and oxygen consumption. This dose-dependent effect clearly predominates in the fron�al regions. In a previous study, our group in vestIgated the effect of piribedil on CBF in humans (Giiell et aI., 1982) : at a dose of 0.2 mg/kg, it results in a global and homogeneous increase in CBF (mean increase 22%); dosed at 0.1 mg/kg, no signifi cant variation occurs in CBF.
Schizophrenics showing a hypofrontality in the basal state were chosen for this dopaminergic stim ulation. The hemodynamic effect of piribedil selec tively influenced the two frontal regions to the ex tent that the mean frontal pattern of the 10 patients increased significantly (Fig. 1 ). Thus, it is possible to confirm that the hypofrontal pattern found in young schizophrenics does not constitute an irre versible situation, as dopaminergic stimulation is ab!e to restore near-normal frontality. Moreover, by usmg a weak dose of piribedil, a dopaminergic hy persensitivity of the frontal regions has been evi denced. Eight of these patients had been receiving neuroleptics over a long period of time, so that the role of washout may logically be suggested in the appearance of this hypersensitivity.
Nevertheless, it was observed that two patients had never received neuroleptics and yet exhibited such hypersensitivity. Based on postmortem studies, Owen et ai. (1978) reported a hypersensi tivity of postsynaptic dopaminergic receptors in schizophrenics who had received no neuroleptics for at least 1 year prior to death. Thus, it is possible �o propose that a primitive dopaminergic depletion, mdependent of treatment, possibly underlies both the decreased activity of the frontal lobes and their dopaminergic hypersensitivity. This is in agreement with the bipolar dopaminergic hypothesis of schizo phrenia (Lecrubier et aI., 1980) : dopaminergic hy perfunctioning in productive forms of the disease dopaminergic hypofunctioning in deficient 0; chronic forms in remission. In order to support such a hypothesis, it will be necessary for us to ef fect . additio�al dopaminergic stimulations in young SChlzophremcs who have hypofrontality, yet have never received neuroleptics. and for giving us their clinical observations concerning these patients.
